Ann: VIRALEZE COVID-19 nasal spray to be ready for market Q1CY21, page-50

I am curious to know whether SPL have approached, or been approached by, BARDA (Biomedical Advanced Research and Development Authority).

Viraleze would seem to be a "perfect strategic fit" for BARDA. Another ASX company I have followed for many years is Avita (AVH) who have been generously funded by BARDA over the years for the development of their Recell technology. I have not seen any reference or speculation re SPL and BARDA.

Having BARDA onside would quickly give Viraleze the international exposure it deserves.

"The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

BARDA works with the biomedical industry, using grants and other assistance, to promote advanced research, innovation and the development of medical devices, tests, vaccines and therapeutics. BARDA also procures and maintains stockpiles of materials, such as drugs, personal protective equipment (PPE) and vaccines, for the Strategic National Stockpile (SNS)."